EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma

Clinical trial NCT02601937 · COMPLETED

Trial details

NCT number: NCT02601937
Sponsor: Epizyme, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rhabdoid Tumors INI1-negative Tumors Synovial Sarcoma Malignant Rhabdoid Tumor of Ovary

Start date: 2016-01-07
Primary completion: 2021-06-19
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.